Table 3.
Travel vaccines.
| Vaccine | Yellow fever | Hepatitis A |
|---|---|---|
| Vaccine type | Yellow fever: live | HepA: inactivated HepA-HepB: inactivated-recombinant |
| At risk individuals | Immunocompetent adults traveling to areas at risk. | Chronic liver disease, HIV, sexual exposure risk, injection or non-injection drug use, homelessness, occupational risk, travelers to endemic areas, or close contact with an international adoptee. |
| Recommendations | A single dose confers lifelong protection. Vaccination is contraindicated in the setting of immunosuppressive therapies. |
A 2-dose series or 3-dose series (HepA-HepB) is recommended. |
1
Recommendations adapted from the CDC guidelines (https://www.cdc.gov/vaccines/schedules/hcp/imz/adult.html).